Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05896332 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

rTMS in Older Adults With MCI and AUD

StatusActive, Not Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Jun 30, 2026 → Nov 30, 2026
See other at-risk trials from Medical University of South Carolina

Record History

  1. Minor Primary and study completion pushed from Jun 30, 2026 to Nov 30, 2026 Eligibility criteria expanded, about 14 words Show 1 more changeShow less
    • Eligibility criteria expanded, about 14 words
  2. Notable Primary completion date: Jul 30, 2025 to Jun 30, 2026 Completion date: Dec 1, 2025 to Jun 30, 2026v7 Show 1 more changeShow less
    • Completion date: Dec 1, 2025 to Jun 30, 2026
  3. Minor Re-verified, no change to tracked fieldsv6
  4. Minor Trial status: Recruiting to Active, Not Recruiting Primary completion date changed from estimate of Jul 1, 2025 to Jul 30, 2025 · Site details revised at 2 of 2 sitesv5 Show 2 more changesShow less
    • Primary completion date changed from estimate of Jul 1, 2025 to Jul 30, 2025
    • Site details revised at 2 of 2 sites
  5. Minor Site contacts updated at 2 of 2 sitesv4
Show 2 earlier versionsHide 2 earlier versions
  1. Notable Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 2 · Start date changed from estimate of Sep 1, 2023 to Nov 1, 2023v3 Show 2 more changesShow less
    • Study sites: 0 to 2
    • Start date changed from estimate of Sep 1, 2023 to Nov 1, 2023
  2. Notable Start date: Jul 1, 2023 to Sep 1, 2023v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Alcohol misuse is a risk factor for early onset cognitive impairment, contributing to 10% of early onset dementia, with risk corresponding to consumption. Additionally, continued drinking risks worsening cognitive decline and dementia progression, while worsening cognitive impairment contributes to drinking escalation. Repetitive transcranial magnetic stimulation (rTMS) has been shown to improve cognition in Alzheimer's Disease and Related Dimentias (ADRD) and separately reduce heavy drinking in alcohol use disorder. Our objective is to optimize rTMS for simultaneous mitigation of both drinking and cognitive dysfunction in older adults.
Trial Details
NCT Number NCT05896332
Lead Sponsor Medical University of South Carolina
Collaborators: National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions Alcohol Use Disorder, Mild Cognitive Impairment, Transcranial Magnetic Stimulation
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov